From 11:00 pm to 12:00 pm EST ( 8:00 pm to 9:00 pm PST ) on January 6th, the website will be under maintenance. We are sorry for the inconvenience. Please arrange your schedule properly.
Sequoyitol (5-O-Methyl-myo-inositol) is isolated from plants. Sequoyitol (5-O-Methyl-myo-inositol) decreases blood glucose, improves glucose intolerance, and is used to treat diabetes .
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber hypertrophy and not hyperplasia in SCID mice. Stamulumab has the potential for Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophy (LGMD) research .
MYO10 Human Pre-designed siRNA Set A contains three designed siRNAs for MYO10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO16 Human Pre-designed siRNA Set A contains three designed siRNAs for MYO16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO19 Human Pre-designed siRNA Set A contains three designed siRNAs for MYO19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO6 Human Pre-designed siRNA Set A contains three designed siRNAs for MYO6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
myo-Inositol trispyrophosphate (ITPP) hexasodium, a modifier of haemoglobin, is an allosteric effector that reduces the oxygen‐binding affinity of haemoglobin and facilitates the release of oxygen by red blood cells. myo-Inositol trispyrophosphate can reverse hypoxia, control tumor growth and improve chemotherapy response .
MYO15A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO15A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO18A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO18A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO1A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO3A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO5A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO9A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO9A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO7A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO7A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
D-myo-Inositol 4-mono-phosphate, also known as IMP, is a phosphorylated form of inositol that is commonly found in various metabolic pathways, especially in the biosynthesis of phospholipids and cell signaling molecules. D-myo-Inositol 4-mono-phosphate has unique chemical properties that make it an important intermediate in the production of second messengers, such as inositol triphosphate (IP3) and diacylglycerol (DAG), which signal in cells plays a key role in. D-myo-Inositol 4-mono-phosphate is also used in dietary supplements and pharmaceuticals because of its potential health benefits, including improved insulin sensitivity and cognitive function.
MYO15B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO15B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO18B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO18B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO1B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO1C Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO1D Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO1E Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO1F Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1F gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO1G Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO3B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO5B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO5C Human Pre-designed siRNA Set A contains three designed siRNAs for MYO5C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO7B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO7B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
MYO9B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO9B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
myo-Inositol trispyrophosphate (ITPP) hexa-triethylamine, a inositol tripyrophosphate (ITPP) salt, is a membrane permeant allosteric effector of haemoglobin .
i-Inositol (myo-Inositol) is a compound of sugar alcohols. i-Inositol is involved in a series of biological processes such as insulin signal transduction and cytoskeletal transduction. i-Inositol mainly exists in glial cells and plays an osmotic role .
Phytic acid sodium salt (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphat) is often present in legume seeds with antinutritional effects. Phytic acid sodium salt is a [PO4] 3- storage depot and precursor for other inositol phosphates and pyrophosphates. phytic acid is hydrolyzed by phytases in a stepwise manner in the plant .
D-myo-Inositol 1,4,5-trisphosphate hexapotassium salt is the hexapotassium salt of D-myo-Inositol 1,4,5-trisphosphate (1,4,5-IP3), which is a second messenger that stimulates the discharge of calcium from the endoplasmic reticulum.
D-myo-Inositol-1,4,5-triphosphate sodium salt is the hexapotassium salt of D-myo-Inositol 1,4,5-trisphosphate (1,4,5-IP3), which is a second messenger that stimulates the discharge of calcium from the endoplasmic reticulum.
D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-hexadecen-1-yl]oxy]propyl hydrogen phosphate]-d5, ammonium salt (1:1) is an isotopically labeled compound.
D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-tetradecen-1-yl]oxy]propyl hydrogen phosphate]-d5, ammonium salt (1:1) is an isotopically labeled compound.
D-chiro-Inositol is an epimer of myo-inositol found in certain mammalian glycosylphosphatidylinositol protein anchors and inositol phosphoglycans possessing insulin-like bioactivity. D-chiro-Inositol is used clinically for the treatment of polycystic ovary syndrome (PCOS) and diabetes mellitus, which can reduce hyperglycemia and ameliorate insulin resistance .
i-Inositol-d6 is the deuterium labeled i-Inositol. i-Inositol is a chemical compound, associated lipids are found in many foods, in particular fruit, especially cantaloupe and oranges.
Pentachloropseudilin (Antibiotic A 15104 Y; PClP) is a reversible and allosteric potent inhibitor of Myo1s (class 1 myosins) with IC50s range from 1 to 5 μM for mammalian class-1 myosins and greater than 90 μM for class-2 and class-5 myosins. Pentachloropseudilin is a potent inhibitor of transforming growth factor-β (TGF-β)-stimulated signaling, with an IC50 of 0.1 to 0.2 μM for TGF-β .
D-myo-Inositol 4-mono-phosphate, also known as IMP, is a phosphorylated form of inositol that is commonly found in various metabolic pathways, especially in the biosynthesis of phospholipids and cell signaling molecules. D-myo-Inositol 4-mono-phosphate has unique chemical properties that make it an important intermediate in the production of second messengers, such as inositol triphosphate (IP3) and diacylglycerol (DAG), which signal in cells plays a key role in. D-myo-Inositol 4-mono-phosphate is also used in dietary supplements and pharmaceuticals because of its potential health benefits, including improved insulin sensitivity and cognitive function.
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber hypertrophy and not hyperplasia in SCID mice. Stamulumab has the potential for Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophy (LGMD) research .
Sequoyitol (5-O-Methyl-myo-inositol) is isolated from plants. Sequoyitol (5-O-Methyl-myo-inositol) decreases blood glucose, improves glucose intolerance, and is used to treat diabetes .
i-Inositol (myo-Inositol) is a compound of sugar alcohols. i-Inositol is involved in a series of biological processes such as insulin signal transduction and cytoskeletal transduction. i-Inositol mainly exists in glial cells and plays an osmotic role .
Phytic acid sodium salt (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphat) is often present in legume seeds with antinutritional effects. Phytic acid sodium salt is a [PO4] 3- storage depot and precursor for other inositol phosphates and pyrophosphates. phytic acid is hydrolyzed by phytases in a stepwise manner in the plant .
D-chiro-Inositol is an epimer of myo-inositol found in certain mammalian glycosylphosphatidylinositol protein anchors and inositol phosphoglycans possessing insulin-like bioactivity. D-chiro-Inositol is used clinically for the treatment of polycystic ovary syndrome (PCOS) and diabetes mellitus, which can reduce hyperglycemia and ameliorate insulin resistance .
D-myo-Inositol 4-mono-phosphate, also known as IMP, is a phosphorylated form of inositol that is commonly found in various metabolic pathways, especially in the biosynthesis of phospholipids and cell signaling molecules. D-myo-Inositol 4-mono-phosphate has unique chemical properties that make it an important intermediate in the production of second messengers, such as inositol triphosphate (IP3) and diacylglycerol (DAG), which signal in cells plays a key role in. D-myo-Inositol 4-mono-phosphate is also used in dietary supplements and pharmaceuticals because of its potential health benefits, including improved insulin sensitivity and cognitive function.
IMPA1 protein provides essential inositol for the synthesis of phosphatidylinositol and polyphosphate inositol. IMPA1 Protein, Human (His) is the recombinant human-derived IMPA1 protein, expressed by E. coli , with N-6*His labeled tag. The total length of IMPA1 Protein, Human (His) is 277 a.a., with molecular weight of ~30.0 kDa.
IMPA2, or Inositol monophosphatase 2, demonstrates enzymatic activity by utilizing various substrates such as myo-inositol monophosphates, scylloinositol 1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'-AMP. Additionally, it has been implicated as the pharmacological target for the action of lithium ions (Li⁺) in the brain. IMPA2 Protein, Human (His) is the recombinant human-derived IMPA2 protein, expressed by E. coli , with N-6*His labeled tag. The total length of IMPA2 Protein, Human (His) is 288 a.a., with molecular weight of ~30.0 kDa.
D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-hexadecen-1-yl]oxy]propyl hydrogen phosphate]-d5, ammonium salt (1:1) is an isotopically labeled compound.
D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-tetradecen-1-yl]oxy]propyl hydrogen phosphate]-d5, ammonium salt (1:1) is an isotopically labeled compound.
i-Inositol-d6 is the deuterium labeled i-Inositol. i-Inositol is a chemical compound, associated lipids are found in many foods, in particular fruit, especially cantaloupe and oranges.